A growing health equity gap continues to impact people living in lower-income countries — which receive a fraction of global health investment, despite bearing 70% of the world’s disease burden. Reduced access to quality medicines and care has severe consequences for health and development, contributing to more than 5 million deaths in low- and middle-income countries each year.
Pfizer’s Accord for a Healthier World aims to help close this gap. Through the accord, Pfizer has committed to provide its full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to 45 lower-income countries. To ensure these medicines and vaccines reach people who need them, Pfizer is also collaborating with several accord-eligible country governments and other partners to explore holistic solutions that aim to address system-level barriers limiting or preventing patient access, based on each country’s national health priorities and needs.
This work includes pursuing more efficient regulatory pathways, as permissible under local regulations, strengthening supply chain logistics and capabilities as well as helping advance health workforce learning and development — with the ultimate goal of improving patient access to care.
Read the full visual story.
About the author
Devex Partnerships
Thanks for reading and for your interest in Devex. In collaboration with our partners, Devex’s partnerships editorial team produces content to promote a partner’s work or perspectives on a particular issue. It gives actors across the global development sector — including nongovernmental organizations, private sector stakeholders, aid agencies and government institutions — the opportunity to go beyond traditional advertising and tell their stories in an impactful way. If you’d like to learn more about how you can shine a spotlight on a particular issue with Devex, please email partnerships@devex.com. We look forward to hearing from you.
